1 Dermatology OTC Medications Market Overview 1.1 Dermatology OTC Medications Product Overview 1.2 Dermatology OTC Medications Market Segment by Type 1.2.1 External Use 1.2.2 Oral 1.3 Global Dermatology OTC Medications Market Size by Type 1.3.1 Global Dermatology OTC Medications Market Size Overview by Type (2016-2027) 1.3.2 Global Dermatology OTC Medications Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Dermatology OTC Medications Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Dermatology OTC Medications Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Dermatology OTC Medications Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Dermatology OTC Medications Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Dermatology OTC Medications Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Dermatology OTC Medications Sales Breakdown by Type (2016-2021) 1.4.2 Europe Dermatology OTC Medications Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Dermatology OTC Medications Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Type (2016-2021) 2 Global Dermatology OTC Medications Market Competition by Company 2.1 Global Top Players by Dermatology OTC Medications Sales (2016-2021) 2.2 Global Top Players by Dermatology OTC Medications Revenue (2016-2021) 2.3 Global Top Players Dermatology OTC Medications Price (2016-2021) 2.4 Global Top Manufacturers Dermatology OTC Medications Manufacturing Base Distribution, Sales Area, Product Type 2.5 Dermatology OTC Medications Market Competitive Situation and Trends 2.5.1 Dermatology OTC Medications Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Dermatology OTC Medications Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2020) 2.7 Date of Key Manufacturers Enter into Dermatology OTC Medications Market 2.8 Key Manufacturers Dermatology OTC Medications Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Dermatology OTC Medications Status and Outlook by Region 3.1 Global Dermatology OTC Medications Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Dermatology OTC Medications Historic Market Size by Region 3.2.1 Global Dermatology OTC Medications Sales in Volume by Region (2016-2021) 3.2.2 Global Dermatology OTC Medications Sales in Value by Region (2016-2021) 3.2.3 Global Dermatology OTC Medications Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Dermatology OTC Medications Forecasted Market Size by Region 3.3.1 Global Dermatology OTC Medications Sales in Volume by Region (2022-2027) 3.3.2 Global Dermatology OTC Medications Sales in Value by Region (2022-2027) 3.3.3 Global Dermatology OTC Medications Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Dermatology OTC Medications by Application 4.1 Dermatology OTC Medications Market Segment by Application 4.1.1 Hospital 4.1.2 Drug Store 4.1.3 Other 4.2 Global Dermatology OTC Medications Market Size by Application 4.2.1 Global Dermatology OTC Medications Market Size Overview by Application (2016-2027) 4.2.2 Global Dermatology OTC Medications Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Dermatology OTC Medications Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Dermatology OTC Medications Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Dermatology OTC Medications Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Dermatology OTC Medications Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Dermatology OTC Medications Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Dermatology OTC Medications Sales Breakdown by Application (2016-2021) 4.3.2 Europe Dermatology OTC Medications Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Dermatology OTC Medications Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Application (2016-2021) 5 North America Dermatology OTC Medications by Country 5.1 North America Dermatology OTC Medications Historic Market Size by Country 5.1.1 North America Dermatology OTC Medications Sales in Volume by Country (2016-2021) 5.1.2 North America Dermatology OTC Medications Sales in Value by Country (2016-2021) 5.2 North America Dermatology OTC Medications Forecasted Market Size by Country 5.2.1 North America Dermatology OTC Medications Sales in Volume by Country (2022-2027) 5.2.2 North America Dermatology OTC Medications Sales in Value by Country (2022-2027) 6 Europe Dermatology OTC Medications by Country 6.1 Europe Dermatology OTC Medications Historic Market Size by Country 6.1.1 Europe Dermatology OTC Medications Sales in Volume by Country (2016-2021) 6.1.2 Europe Dermatology OTC Medications Sales in Value by Country (2016-2021) 6.2 Europe Dermatology OTC Medications Forecasted Market Size by Country 6.2.1 Europe Dermatology OTC Medications Sales in Volume by Country (2022-2027) 6.2.2 Europe Dermatology OTC Medications Sales in Value by Country (2022-2027) 7 Asia-Pacific Dermatology OTC Medications by Region 7.1 Asia-Pacific Dermatology OTC Medications Historic Market Size by Region 7.1.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Dermatology OTC Medications Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Dermatology OTC Medications Forecasted Market Size by Region 7.2.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Dermatology OTC Medications Sales in Value by Region (2022-2027) 8 Latin America Dermatology OTC Medications by Country 8.1 Latin America Dermatology OTC Medications Historic Market Size by Country 8.1.1 Latin America Dermatology OTC Medications Sales in Volume by Country (2016-2021) 8.1.2 Latin America Dermatology OTC Medications Sales in Value by Country (2016-2021) 8.2 Latin America Dermatology OTC Medications Forecasted Market Size by Country 8.2.1 Latin America Dermatology OTC Medications Sales in Volume by Country (2022-2027) 8.2.2 Latin America Dermatology OTC Medications Sales in Value by Country (2022-2027) 9 Middle East and Africa Dermatology OTC Medications by Country 9.1 Middle East and Africa Dermatology OTC Medications Historic Market Size by Country 9.1.1 Middle East and Africa Dermatology OTC Medications Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Dermatology OTC Medications Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Dermatology OTC Medications Forecasted Market Size by Country 9.2.1 Middle East and Africa Dermatology OTC Medications Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Dermatology OTC Medications Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Dermatology OTC Medications Business 10.1 Bayer 10.1.1 Bayer Corporation Information 10.1.2 Bayer Introduction and Business Overview 10.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Bayer Dermatology OTC Medications Products Offered 10.1.5 Bayer Recent Development 10.2 GSK 10.2.1 GSK Corporation Information 10.2.2 GSK Introduction and Business Overview 10.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.2.4 GSK Dermatology OTC Medications Products Offered 10.2.5 GSK Recent Development 10.3 Teva 10.3.1 Teva Corporation Information 10.3.2 Teva Introduction and Business Overview 10.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Teva Dermatology OTC Medications Products Offered 10.3.5 Teva Recent Development 10.4 Johnson & Johnson 10.4.1 Johnson & Johnson Corporation Information 10.4.2 Johnson & Johnson Introduction and Business Overview 10.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered 10.4.5 Johnson & Johnson Recent Development 10.5 Novartis 10.5.1 Novartis Corporation Information 10.5.2 Novartis Introduction and Business Overview 10.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Novartis Dermatology OTC Medications Products Offered 10.5.5 Novartis Recent Development 10.6 Mylan 10.6.1 Mylan Corporation Information 10.6.2 Mylan Introduction and Business Overview 10.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Mylan Dermatology OTC Medications Products Offered 10.6.5 Mylan Recent Development 10.7 Sun Pharmaceutical 10.7.1 Sun Pharmaceutical Corporation Information 10.7.2 Sun Pharmaceutical Introduction and Business Overview 10.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered 10.7.5 Sun Pharmaceutical Recent Development 10.8 Aurobindo 10.8.1 Aurobindo Corporation Information 10.8.2 Aurobindo Introduction and Business Overview 10.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Aurobindo Dermatology OTC Medications Products Offered 10.8.5 Aurobindo Recent Development 10.9 Galderma 10.9.1 Galderma Corporation Information 10.9.2 Galderma Introduction and Business Overview 10.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Galderma Dermatology OTC Medications Products Offered 10.9.5 Galderma Recent Development 10.10 CR SANJIU 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Dermatology OTC Medications Product Category, Application and Specification 10.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 CR SANJIU Recent Development 10.11 Dr. Reddy's 10.11.1 Dr. Reddy's Corporation Information 10.11.2 Dr. Reddy's Introduction and Business Overview 10.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Dr. Reddy's Dermatology OTC Medications Products Offered 10.11.5 Dr. Reddy's Recent Development 10.12 Lupin 10.12.1 Lupin Corporation Information 10.12.2 Lupin Introduction and Business Overview 10.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Lupin Dermatology OTC Medications Products Offered 10.12.5 Lupin Recent Development 10.13 Bausch Health 10.13.1 Bausch Health Corporation Information 10.13.2 Bausch Health Introduction and Business Overview 10.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Bausch Health Dermatology OTC Medications Products Offered 10.13.5 Bausch Health Recent Development 10.14 Cipla 10.14.1 Cipla Corporation Information 10.14.2 Cipla Introduction and Business Overview 10.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Cipla Dermatology OTC Medications Products Offered 10.14.5 Cipla Recent Development 10.15 Qilu Pharmaceutical 10.15.1 Qilu Pharmaceutical Corporation Information 10.15.2 Qilu Pharmaceutical Introduction and Business Overview 10.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.15.4 Qilu Pharmaceutical Dermatology OTC Medications Products Offered 10.15.5 Qilu Pharmaceutical Recent Development 10.16 Almirall 10.16.1 Almirall Corporation Information 10.16.2 Almirall Introduction and Business Overview 10.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.16.4 Almirall Dermatology OTC Medications Products Offered 10.16.5 Almirall Recent Development 10.17 Lingrui 10.17.1 Lingrui Corporation Information 10.17.2 Lingrui Introduction and Business Overview 10.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 10.17.4 Lingrui Dermatology OTC Medications Products Offered 10.17.5 Lingrui Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Dermatology OTC Medications Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Dermatology OTC Medications Industrial Chain Analysis 11.4 Dermatology OTC Medications Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Dermatology OTC Medications Distributors 12.3 Dermatology OTC Medications Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of External Use Table 2. Major Company of Oral Table 3. Global Dermatology OTC Medications Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Dermatology OTC Medications Sales by Type (2016-2021) & (M Units) Table 5. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2016-2021) Table 6. Global Dermatology OTC Medications Sales by Type (2016-2021) & (US& Million) Table 7. Global Dermatology OTC Medications Market Share in Value by Type (2016-2021) Table 8. Global Dermatology OTC Medications Price by Type (2016-2021) & (USD/Unit) Table 9. Global Dermatology OTC Medications Sales by Type (2022-2027) & (M Units) Table 10. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2022-2027) Table 11. Global Dermatology OTC Medications Sales by Type (2022-2027) & (US$ Million) Table 12. Global Dermatology OTC Medications Sales Market Share in Value by Type (2022-2027) Table 13. Global Dermatology OTC Medications Price by Type (2022-2027) & (USD/Unit) Table 14. North America Dermatology OTC Medications Sales by Type (2016-2021) & (M Units) Table 15. North America Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Dermatology OTC Medications Sales (M Units) by Type (2016-2021) Table 17. Europe Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Dermatology OTC Medications Sales (M Units) by Type (2016-2021) Table 19. Asia-Pacific Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Dermatology OTC Medications Sales (M Units) by Type (2016-2021) Table 21. Latin America Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Dermatology OTC Medications Sales (M Units) by Type (2016-2021) Table 23. Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million) Table 24. Global Dermatology OTC Medications Sales by Company (2016-2021) & (M Units) Table 25. Global Dermatology OTC Medications Sales Share by Company (2016-2021) Table 26. Global Dermatology OTC Medications Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Dermatology OTC Medications Revenue Share by Company (2016-2021) Table 28. Global Market Dermatology OTC Medications Price by Company (2016-2021) & (USD/Unit) Table 29. Global Dermatology OTC Medications Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2020 Table 32. Date of Key Manufacturers Enter into Dermatology OTC Medications Market Table 33. Key Manufacturers Dermatology OTC Medications Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Dermatology OTC Medications Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Dermatology OTC Medications Sales by Region (2016-2021) & (M Units) Table 37. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2016-2021) Table 38. Global Dermatology OTC Medications Sales by Region (2016-2021) & (US$ Million) Table 39. Global Dermatology OTC Medications Sales Market Share in Value by Region (2016-2021) Table 40. Global Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 41. Global Dermatology OTC Medications Sales by Region (2022-2027) & (M Units) Table 42. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2022-2027) Table 43. Global Dermatology OTC Medications Sales by Region (2022-2027) & (US$ Million) Table 44. Global Dermatology OTC Medications Sales Market Share in Value by Region (2022-2027) Table 45. Global Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027) Table 46. Global Dermatology OTC Medications Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Dermatology OTC Medications Sales by Application (2016-2021) & (M Units) Table 48. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2016-2021) Table 49. Global Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million) Table 50. Global Dermatology OTC Medications Sales Market Share in Value by Application (2016-2021) Table 51. Global Dermatology OTC Medications Price by Application (2016-2021) & (USD/Unit) Table 52. Global Dermatology OTC Medications Sales by Application (2022-2027) & (M Units) Table 53. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2022-2027) Table 54. Global Dermatology OTC Medications Sales by Application (2022-2027) & (US$ Million) Table 55. Global Dermatology OTC Medications Sales Market Share in Value by Application (2022-2027) Table 56. Global Dermatology OTC Medications Price by Application (2022-2027) & (USD/Unit) Table 57. North America Dermatology OTC Medications Sales by Application (2016-2021) (M Units) Table 58. North America Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million) Table 59. North America Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Table 60. Europe Dermatology OTC Medications Sales by Application (2016-2021) (M Units) Table 61. Europe Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Dermatology OTC Medications Sales by Application (2016-2021) (M Units) Table 64. Asia-Pacific Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Table 66. Latin America Dermatology OTC Medications Sales by Application (2016-2021) (M Units) Table 67. Latin America Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2021) (M Units) Table 70. Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Table 72. North America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 73. North America Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021) Table 74. North America Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million) Table 75. North America Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021) Table 76. North America Dermatology OTC Medications Sales by Country (2022-2027) & (M Units) Table 77. North America Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027) Table 78. North America Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million) Table 79. North America Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027) Table 80. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 81. Europe Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021) Table 84. Europe Dermatology OTC Medications Sales by Country (2022-2027) & (M Units) Table 85. Europe Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (M Units) Table 89. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Dermatology OTC Medications Sales by Region (2022-2027) & (M Units) Table 93. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Dermatology OTC Medications Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 97. Latin America Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Dermatology OTC Medications Sales by Country (2022-2027) & (M Units) Table 101. Latin America Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 105. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Dermatology OTC Medications Sales by Country (2022-2027) & (M Units) Table 109. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027) Table 112. Bayer Corporation Information Table 113. Bayer Introduction and Business Overview Table 114. Bayer Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 115. Bayer Dermatology OTC Medications Product Table 116. Bayer Recent Development Table 117. GSK Corporation Information Table 118. GSK Introduction and Business Overview Table 119. GSK Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 120. GSK Dermatology OTC Medications Product Table 121. GSK Recent Development Table 122. Teva Corporation Information Table 123. Teva Introduction and Business Overview Table 124. Teva Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 125. Teva Dermatology OTC Medications Product Table 126. Teva Recent Development Table 127. Johnson & Johnson Corporation Information Table 128. Johnson & Johnson Introduction and Business Overview Table 129. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 130. Johnson & Johnson Dermatology OTC Medications Product Table 131. Johnson & Johnson Recent Development Table 132. Novartis Corporation Information Table 133. Novartis Introduction and Business Overview Table 134. Novartis Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 135. Novartis Dermatology OTC Medications Product Table 136. Novartis Recent Development Table 137. Mylan Corporation Information Table 138. Mylan Introduction and Business Overview Table 139. Mylan Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 140. Mylan Dermatology OTC Medications Product Table 141. Mylan Recent Development Table 142. Sun Pharmaceutical Corporation Information Table 143. Sun Pharmaceutical Introduction and Business Overview Table 144. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 145. Sun Pharmaceutical Dermatology OTC Medications Product Table 146. Sun Pharmaceutical Recent Development Table 147. Aurobindo Corporation Information Table 148. Aurobindo Introduction and Business Overview Table 149. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 150. Aurobindo Dermatology OTC Medications Product Table 151. Aurobindo Recent Development Table 152. Galderma Corporation Information Table 153. Galderma Introduction and Business Overview Table 154. Galderma Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 155. Galderma Dermatology OTC Medications Product Table 156. Galderma Recent Development Table 157. CR SANJIU Corporation Information Table 158. CR SANJIU Introduction and Business Overview Table 159. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 160. CR SANJIU Dermatology OTC Medications Product Table 161. CR SANJIU Recent Development Table 162. Dr. Reddy's Corporation Information Table 163. Dr. Reddy's Introduction and Business Overview Table 164. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 165. Dr. Reddy's Dermatology OTC Medications Product Table 166. Dr. Reddy's Recent Development Table 167. Lupin Corporation Information Table 168. Lupin Introduction and Business Overview Table 169. Lupin Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 170. Lupin Dermatology OTC Medications Product Table 171. Lupin Recent Development Table 172. Bausch Health Corporation Information Table 173. Bausch Health Introduction and Business Overview Table 174. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 175. Bausch Health Dermatology OTC Medications Product Table 176. Bausch Health Recent Development Table 177. Cipla Corporation Information Table 178. Cipla Introduction and Business Overview Table 179. Cipla Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 180. Cipla Dermatology OTC Medications Product Table 181. Cipla Recent Development Table 182. Qilu Pharmaceutical Corporation Information Table 183. Qilu Pharmaceutical Introduction and Business Overview Table 184. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 185. Qilu Pharmaceutical Dermatology OTC Medications Product Table 186. Qilu Pharmaceutical Recent Development Table 187. Almirall Corporation Information Table 188. Almirall Introduction and Business Overview Table 189. Almirall Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 190. Almirall Dermatology OTC Medications Product Table 191. Almirall Recent Development Table 192. Lingrui Corporation Information Table 193. Lingrui Introduction and Business Overview Table 194. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 195. Lingrui Dermatology OTC Medications Product Table 196. Lingrui Recent Development Table 197. Key Raw Materials Lists Table 198. Raw Materials Key Suppliers Lists Table 199. Dermatology OTC Medications Market Trends Table 200. Dermatology OTC Medications Market Drivers Table 201. Dermatology OTC Medications Market Challenges Table 202. Dermatology OTC Medications Market Restraints Table 203. Dermatology OTC Medications Distributors List Table 204. Dermatology OTC Medications Downstream Customers Table 205. Research Programs/Design for This Report Table 206. Key Data Information from Secondary Sources Table 207. Key Data Information from Primary Sources List of Figures Figure 1. Dermatology OTC Medications Product Picture Figure 2. Global Dermatology OTC Medications Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Dermatology OTC Medications Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Dermatology OTC Medications Sales Status and Outlook (2016-2027) & (M Units) Figure 5. Product Picture of External Use Figure 6. Global External Use Sales YoY Growth (2016-2021) & (M Units) Figure 7. Product Picture of Oral Figure 8. Global Oral Sales YoY Growth (2016-2021) & (M Units) Figure 9. Global Dermatology OTC Medications Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Dermatology OTC Medications Sales Market Share in Value by Type (2016-2021) Figure 12. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Dermatology OTC Medications Sales Market Share in Value by Type (2022-2027) Figure 14. North America Dermatology OTC Medications Sales Market Share in Volume by Type in 2020 Figure 15. North America Dermatology OTC Medications Sales Market Share in Value by Type in 2020 Figure 16. Europe Dermatology OTC Medications Sales Market Share in Volume by Type in 2020 Figure 17. Europe Dermatology OTC Medications Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Type in 2020 Figure 20. Latin America Dermatology OTC Medications Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Dermatology OTC Medications Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Revenue in 2020 Figure 26. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (M Units) Figure 29. Product Picture of Drug Store Figure 30. Global Drug Store Sales YoY Growth (2016-2027) & (M Units) Figure 31. Product Picture of Other Figure 32. Global Other Sales YoY Growth (2016-2027) & (M Units) Figure 33. Global Dermatology OTC Medications Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Dermatology OTC Medications Sales Market Share in Value by Application (2016-2021) Figure 36. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Dermatology OTC Medications Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Dermatology OTC Medications Manufacturing Cost Structure Figure 42. Dermatology OTC Medications Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Bayer GSK Teva Johnson & Johnson Novartis Mylan Sun Pharmaceutical Aurobindo Galderma CR SANJIU Dr. Reddy's Lupin Bausch Health Cipla Qilu Pharmaceutical Almirall Lingrui